Related Experiment Video
Updated: Apr 25, 2026
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
14.7K
Engaging providers in medication adherence: a health plan case study.
1Clinical Pharmacy Specialist, Highmark, Inc, Pittsburgh, PA.
American Health & Drug Benefits
|August 16, 2014
Summary
This study highlights how engaging healthcare providers improves patient medication adherence. Identifying barriers like cost and understanding helps create personalized strategies to overcome nonadherence challenges.
Area of Science:
- Primary Care
- Health Outcomes
- Medication Adherence
Background:
- Treatment regimen nonadherence is a prevalent issue in primary care.
- It presents significant costs and complexities, often overlooked in clinical practice.
Purpose of the Study:
- Increase provider awareness of patient nonadherence.
- Identify specific barriers contributing to poor adherence.
- Engage physicians in developing solutions for medication adherence.
Main Methods:
- Utilized prescription data for therapy gap analysis to identify nonadherent patients.
- Conducted chart reviews and patient outreach to refine samples.
- Practices identified adherence barriers and developed tailored action steps.
Main Results:
- Identified barriers include prescription cost, complex medication regimens, and patient/family understanding.
- Cost was a significant factor, with 33% of patients in one practice stopping medication due to expense.
- Pediatric adherence was affected by parents altering medication schedules during weekends/holidays.
Conclusions:
- Provider engagement is crucial for improving medication adherence.
- Addressing nonadherence requires personalized strategies based on identified patient-specific barriers.
- Making adherence a personal provider concern is key to overcoming barriers.
Related Concept Videos
01:28Drug Therapy
443
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
443
01:15Drug Dosing: Geriatric Patients
392
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
01:15Methods of Documentation VI: Case Management Model
922
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
922
01:29Therapeutic Drug Monitoring: Affecting Factors
428
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
428
01:15Drug Dosage Regimen: Overview
4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
241
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
241